menu
    • menu

    Company profile for C4 Therapeutics

    NEW Drugs in Dev: 6
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    C4 Therapeutics® is committed to transforming the treatment of cancer, neurological, and other important diseases with novel therapies that eliminate disease-causing proteins. Our approach to medicine harnesses the innate machinery of the cell to attack disease and potentially bring deep and durable responses to patients. C4 Therapeutics is pioneering a new class of drugs. C4’s technology platform produces small molecule dr...
    C4 Therapeutics® is committed to transforming the treatment of cancer, neurological, and other important diseases with novel therapies that eliminate disease-causing proteins. Our approach to medicine harnesses the innate machinery of the cell to attack disease and potentially bring deep and durable responses to patients. C4 Therapeutics is pioneering a new class of drugs. C4’s technology platform produces small molecule drugs that harness machinery already present in cells to selectively target disease-relevant proteins for degradation. Our approach has the potential to address a broad range of diseases including cancer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    C4 TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    490 Arsenal Way, Suite 200 Watertown, MA 02472
    Telephone
    Telephone
    (617) 231-0700
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://c4therapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/c4-therapeutics-inc./
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/C4Therapeutics

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BioProcess International US West

    Not Confirmed

    envelop Contact Supplier

    BioProcess International US West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    C4 Therapeutics To Participate In Upcoming March Conferences
    C4 Therapeutics To Participate In Upcoming March Conferences

    23 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/23/3242501/0/en/C4-Therapeutics-to-Participate-in-Upcoming-March-Conferences.html

    GLOBENEWSWIRE
    23 Feb 2026
    Share Share
    C4 Therapeutics Doses First Patient in Phase 2 MOMENTUM Trial
    C4 Therapeutics Doses First Patient in Phase 2 MOMENTUM Trial

    23 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/23/3242470/0/en/C4-Therapeutics-Announces-First-Patient-Dosed-in-Phase-2-MOMENTUM-Trial-of-Cemsidomide-an-Oral-IKZF1-3-Degrader-in-Combination-with-Dexamethasone-for-Relapsed-Refractory-Multiple-M.html

    GLOBENEWSWIRE
    23 Feb 2026
    Share Share
    C4 Therapeutics Inducement Grant Under Nasdaq Lr 5635(C)(4)
    C4 Therapeutics Inducement Grant Under Nasdaq Lr 5635(C)(4)

    09 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/09/3234884/0/en/C4-Therapeutics-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    09 Feb 2026
    Share Share
    C4 Therapeutics Joins Guggenheim Biotech Summit 2026
    C4 Therapeutics Joins Guggenheim Biotech Summit 2026

    04 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/04/3231883/0/en/C4-Therapeutics-to-Participate-in-the-Guggenheim-Emerging-Outlook-Biotech-Summit-2026.html

    GLOBENEWSWIRE
    04 Feb 2026
    Share Share
    C4 Therapeutics Awards Inducement Grant Under Nasdaq Rule
    C4 Therapeutics Awards Inducement Grant Under Nasdaq Rule

    26 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/26/3225968/0/en/C4-Therapeutics-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    26 Jan 2026
    Share Share
    C4 Therapeutics Advances Cemsidomide As Top IKZF1/3 Degrader
    C4 Therapeutics Advances Cemsidomide As Top IKZF1/3 Degrader

    14 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/14/3218491/0/en/C4-Therapeutics-Outlines-Strategic-Milestones-to-Advance-Cemsidomide-as-a-Potential-Best-in-Class-IKZF1-3-Degrader-and-Discovery-Strategy-Focused-on-Novel-Targets-in-Clinically-Val.html

    GLOBENEWSWIRE
    14 Jan 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search